Journal of Clinical Endocrinology & Metabolism, Vol 80, 2322-2329, Copyright © 1995 by Endocrine Society

ARTICLES

Steroid 21-hydroxylase deficiency: genotype may not predict phenotype

RC Wilson, AB Mercado, KC Cheng and MI New
Department of Pediatrics, New York Hospital-Cornell Medical Center, New York 10021, USA.

Steroid 21-hydroxylase deficiency is the most frequent cause of congenital adrenal hyperplasia. We have determined the 21-hydroxylase genotype in 197 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency and assessed phenotypic characteristics based on 1) genital status with respect to virilization in females, 2) ACTH stimulation tests to evaluate the secretion of androgens and 17- hydroxyprogesterone, and 3) salt deprivation tests to precisely describe the phenotype with respect to aldosterone deficiency and salt wasting. After dividing our patients into 26 21-hydroxylase gene mutation-identical groups, we found that, in general, the patient's phenotype matched the severity of the genotype. However, in 13 of these groups, the genotype did not always predict the phenotype, even within families. This study, has demonstrated that the 10 most common mutations observed in the 21-hydroxylase gene result in phenotypes that are not always concordant with the genotype.

This article has been cited by other articles:

				L. G. Gomes, N. Huang, V. Agrawal, B. B. Mendonca, T. A. S. S. Bachega, and W. L. Miller The Common P450 Oxidoreductase Variant A503V Is Not a Modifier Gene for 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2913 - 2916. [Abstract] [Full Text] [PDF]

				K. LIN-SU, S. NIMKARN, and M. I. NEW Congenital Adrenal Hyperplasia in Adolescents: Diagnosis and Management Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 95 - 98. [Abstract] [Full Text] [PDF]

				R. Menassa, V. Tardy, F. Despert, C. Bouvattier-Morel, J. P. Brossier, M. Cartigny, and Y. Morel p.H62L, a Rare Mutation of the CYP21 Gene Identified in Two Forms of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1901 - 1908. [Abstract] [Full Text] [PDF]

				R. S. Araujo, B. B. Mendonca, A. S. Barbosa, C. J. Lin, J. A. M. Marcondes, A. E. C. Billerbeck, and T. A. S. S. Bachega Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4028 - 4034. [Abstract] [Full Text] [PDF]

				S. Nimkarn, K. Lin-Su, N. Berglind, R. C. Wilson, and M. I. New Aldosterone-to-Renin Ratio as a Marker for Disease Severity in 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 137 - 142. [Abstract] [Full Text] [PDF]

				O. Porzio, V. Cunsolo, M. Malaponti, E. De Nisco, A. Acquafredda, L. Cavallo, M. Andreani, E. Giardina, M. Testi, M. Cappa, et al. Divergent Phenotype of Two Siblings Human Leukocyte Antigen Identical, Affected by Nonclassical and Classical Congenital Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4510 - 4513. [Abstract] [Full Text] [PDF]

				M. I. New Nonclassical 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4205 - 4214. [Abstract] [Full Text] [PDF]

				A Luczay, D Torok, A Ferenczi, J Majnik, J Solyom, and G. Fekete Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency. Eur. J. Endocrinol., June 1, 2006; 154(6): 859 - 864. [Abstract] [Full Text] [PDF]

				A. T. Soliman, M. Omar, M. Al Ali, M. M. Rizk, I. Nasr, and M. AbolMagd Congenital Adrenal Hyperplasia: Family Screening Using 17-hydroxyprogesterone (17-OHP) Response to Adrenocorticotopin (ACTH) J Trop Pediatr, April 1, 2006; 52(2): 147 - 148. [Full Text] [PDF]

				K. Prank, E. Schulze, O. Eckert, T. W Nattkemper, M. Bettendorf, C. Maser-Gluth, T. J Sejnowski, A. Grote, E. Penner, A. von zur Muhlen, et al. Machine learning approaches for phenotype-genotype mapping: predicting heterozygous mutations in the CYP21B gene from steroid profiles Eur. J. Endocrinol., August 1, 2005; 153(2): 301 - 305. [Abstract] [Full Text] [PDF]

				V Dolz;an, J Solyom, G Fekete, J Kovacs, V Rakosnikova, F Votava, J Lebl, Z Pribilincova, S. Baumgartner-Parzer, S Riedl, et al. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia Eur. J. Endocrinol., July 1, 2005; 153(1): 99 - 106. [Abstract] [Full Text] [PDF]

				D. Keen-Kim, J. B. Redman, R. U. Alanes, M. M. Eachus, R. C. Wilson, M. I. New, J. M. Nakamoto, and R. G. Fenwick Validation and Clinical Application of a Locus-Specific Polymerase Chain Reaction- and Minisequencing-Based Assay for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) J. Mol. Diagn., May 1, 2005; 7(2): 236 - 246. [Abstract] [Full Text] [PDF]

				T. Robins, M. Barbaro, S. Lajic, and A. Wedell Not All Amino Acid Substitutions of the Common Cluster E6 Mutation in CYP21 Cause Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2148 - 2153. [Abstract] [Full Text] [PDF]

				S. M. Baumgartner-Parzer, P. Nowotny, G. Heinze, W. Waldhausl, and H. Vierhapper Carrier Frequency of Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in a Middle European Population J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 775 - 778. [Abstract] [Full Text] [PDF]

				N. Krone, F. G. Riepe, J. Grotzinger, C.-J. Partsch, and W. G. Sippell Functional Characterization of Two Novel Point Mutations in the CYP21 Gene Causing Simple Virilizing Forms of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 445 - 454. [Abstract] [Full Text] [PDF]

				M. I. NEW An Update of Congenital Adrenal Hyperplasia Ann. N.Y. Acad. Sci., December 1, 2004; 1038(1): 14 - 43. [Abstract] [Full Text] [PDF]

				C. M. Hall, J. A. Jones, H. F. L. Meyer-Bahlburg, C. Dolezal, M. Coleman, P. Foster, D. A. Price, and P. E. Clayton Behavioral and Physical Masculinization Are Related to Genotype in Girls with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 419 - 424. [Abstract] [Full Text] [PDF]

				T. Tukel, O. Uyguner, J. Q. Wei, M. Yuksel-Apak, N. Saka, D. X. Song, H. Kayserili, F. Bas, H. Gunoz, R. C. Wilson, et al. A Novel Semiquantitative Polymerase Chain Reaction/Enzyme Digestion-Based Method for Detection of Large Scale Deletions/Conversions of the CYP21 Gene and Mutation Screening in Turkish Families with 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5893 - 5897. [Abstract] [Full Text] [PDF]

				P. W. Speiser and P. C. White Congenital Adrenal Hyperplasia N. Engl. J. Med., August 21, 2003; 349(8): 776 - 788. [Full Text] [PDF]

				N. M. M. L. Stikkelbroeck, L. H. Hoefsloot, I. J. de Wijs, B. J. Otten, A. R. M. M. Hermus, and E. A. Sistermans CYP21 Gene Mutation Analysis in 198 Patients with 21-Hydroxylase Deficiency in The Netherlands: Six Novel Mutations and a Specific Cluster of Four Mutations J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3852 - 3859. [Abstract] [Full Text] [PDF]

				G. Pinto, V. Tardy, C. Trivin, C. Thalassinos, S. Lortat-Jacob, C. Nihoul-Fekete, Y. Morel, and R. Brauner Follow-Up of 68 Children with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Relevance of Genotype for Management J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2624 - 2633. [Abstract] [Full Text] [PDF]

				P F J Koppens, H J M Smeets, I J de Wijs, and H J Degenhart Mapping of a de novo unequal crossover causing a deletion of the steroid 21-hydroxylase (CYP21A2) gene and a non-functional hybrid tenascin-X (TNXB) gene J. Med. Genet., May 1, 2003; 40(5): e53 - 53. [Full Text] [PDF]

				E. Charmandari, G. Eisenhofer, S. L. Mehlinger, A. Carlson, R. Wesley, M. F. Keil, G. P. Chrousos, M. I. New, and D. P. Merke Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3031 - 3037. [Abstract] [Full Text] [PDF]

				Y. L. Giwercman, A. Nordenskjold, E. M. Ritzen, K. O. Nilsson, S.-A. Ivarsson, U. Grandell, and A. Wedell An Androgen Receptor Gene Mutation (E653K) in a Family with Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency as well as in Partial Androgen Insensitivity J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2623 - 2628. [Abstract] [Full Text] [PDF]

				S. Koyama, T. Toyoura, S. Saisho, K. Shimozawa, and J. Yata Genetic Analysis of Japanese Patients with 21-Hydroxylase Deficiency: Identification of a Patient with a New Mutation of a Homozygous Deletion of Adenine at Codon 246 and Patients without Demonstrable Mutations within the Structural Gene for CYP21 J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2668 - 2673. [Abstract] [Full Text] [PDF]

				S. Lajic, S. Clauin, T. Robins, P. Vexiau, H. Blanche, C. Bellanne-Chantelot, and A. Wedell Novel Mutations in CYP21 Detected in Individuals with Hyperandrogenism J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2824 - 2829. [Abstract] [Full Text] [PDF]

				D. P. Merke, S. R. Bornstein, N. A. Avila, and G. P. Chrousos Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Ann Intern Med, February 19, 2002; 136(4): 320 - 334. [Abstract] [Full Text] [PDF]

				R. C. Olney, E. B. Mougey, J. Wang, D. I. Shulman, and J. E. Sylvester Using Real-Time, Quantitative PCR for Rapid Genotyping of the Steroid 21-Hydroxylase Gene in a North Florida Population J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 735 - 741. [Abstract] [Full Text] [PDF]

				M. I. New, A. Carlson, J. Obeid, I. Marshall, M. S. Cabrera, A. Goseco, K. Lin-Su, A. S. Putnam, J. Q. Wei, and R. C. Wilson EXTENSIVE PERSONAL EXPERIENCE: Prenatal Diagnosis for Congenital Adrenal Hyperplasia in 532 Pregnancies J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5651 - 5657. [Abstract] [Full Text] [PDF]

				A. Nordenstrom, A. Wedell, L. Hagenfeldt, C. Marcus, and A. Larsson Neonatal Screening for Congenital Adrenal Hyperplasia: 17-Hydroxyprogesterone Levels and CYP21 Genotypes in Preterm Infants Pediatrics, October 1, 2001; 108(4): e68 - 68. [Abstract] [Full Text] [PDF]

				M. Dracopoulou-Vabouli, M. Maniati-Christidi, and C. Dacou-Voutetakis The Spectrum of Molecular Defects of the CYP21 Gene in the Hellenic Population: Variable Concordance between Genotype and Phenotype in the Different Forms of Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2845 - 2848. [Abstract] [Full Text] [PDF]

				C. E. Keegan and A. A. Killeen An Overview of Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency J. Mol. Diagn., May 1, 2001; 3(2): 49 - 54. [Full Text]

				C. Deneux, V. Tardy, A. Dib, E. Mornet, L. Billaud, D. Charron, Y. Morel, and F. Kuttenn Phenotype-Genotype Correlation in 56 Women with Nonclassical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 207 - 213. [Abstract] [Full Text]

				D. l’Allemand, V. Tardy, A. Grüters, D. Schnabel, H. Krude, and Y. Morel How a Patient Homozygous for a 30-kb Deletion of the C4-CYP 21 Genomic Region Can Have a Nonclassic Form of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4562 - 4567. [Abstract] [Full Text]

				P. C. White and P. W. Speiser Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Endocr. Rev., June 1, 2000; 21(3): 245 - 291. [Abstract] [Full Text]

				N. Krone, A. Braun, A. A. Roscher, D. Knorr, and H. P. Schwarz Predicting Phenotype in Steroid 21-Hydroxylase Deficiency? Comprehensive Genotyping in 155 Unrelated, Well Defined Patients from Southern Germany J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1059 - 1065. [Abstract] [Full Text]

				D. P. Merke, M. F. Keil, J. V. Jones, J. Fields, S. Hill, and G. B. Cutler Jr. Flutamide, Testolactone, and Reduced Hydrocortisone Dose Maintain Normal Growth Velocity and Bone Maturation Despite Elevated Androgen Levels in Children with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1114 - 1120. [Abstract] [Full Text]

				M. I. New and R. C. Wilson Steroid disorders in children: Congenital adrenal hyperplasia and apparent mineralocorticoid excess PNAS, October 26, 1999; 96(22): 12790 - 12797. [Abstract] [Full Text] [PDF]

				B. I. Cerame, R. S. Newfield, L. Pascoe, K. M. Curnow, S. Nimkarn, T. F. Roe, M. I. New, and R. C. Wilson Prenatal Diagnosis and Treatment of 11{beta}-Hydroxylase Deficiency Congenital Adrenal Hyperplasia Resulting in Normal Female Genitalia J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3129 - 3134. [Abstract] [Full Text]

				A. E. C. Billerbeck, T. A. S. S. Bachega, E. T. Frazzatto, M. Y. Nishi, A. C. Goldberg, M. L. C. Marin, G. Madureira, O. Monte, I. J. P. Arnhold, and B. B. Mendonca A Novel Missense Mutation, GLY424SER, in Brazilian Patients with 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2870 - 2872. [Abstract] [Full Text]

				A BOBBA, E MARRA, S GIANNATTASIO, A IOLASCON, F MONNO, and S DI MAIO 21-hydroxylase deficiency in Italy: a distinct distribution pattern of CYP21 mutations in a sample from southern Italy J. Med. Genet., August 1, 1999; 36(8): 648 - 650. [Full Text]

				A. Ferenczi, M. Garami, E. Kiss, M. Pék, M. Sasvári-Székely, C. Barta, M. Staub, J. Sólyom, and G. Fekete Screening for Mutations of 21-Hydroxylase Gene in Hungarian Patients with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2369 - 2372. [Abstract] [Full Text]

				A. Nordenström, A. Thilén, L. Hagenfeldt, A. Larsson, and A. Wedell Genotyping Is a Valuable Diagnostic Complement to Neonatal Screening for Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1505 - 1509. [Abstract] [Full Text]

				A. Nordenström, C. Marcus, M. Axelson, A. Wedell, and E. M. Ritzén Failure of Cortisone Acetate Treatment in Congenital Adrenal Hyperplasia because of Defective 11{beta}-Hydroxysteroid Dehydrogenase Reductase Activity J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1210 - 1213. [Abstract] [Full Text]

				M. Lako, S. Ramsden, R D. Campbell, and T. Strachan Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis J. Med. Genet., February 1, 1999; 36(2): 119 - 124. [Abstract] [Full Text]

				T. A. S. S. Bachega, A. E. C. Billerbeck, G. Madureira, J. A. M. Marcondes, C. A. Longui, M. V. Leite, I. J. P. Arnhold, and B. B. Mendonca Molecular Genotyping in Brazilian Patients with the Classical and Nonclassical Forms of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4416 - 4419. [Abstract] [Full Text]

				D. Chin, P. W. Speiser, J. Imperato-McGinley, N. Dixit, N. Uli, R. David, and S. E. Oberfield Study of a Kindred with Classic Congenital Adrenal Hyperplasia: Diagnostic Challenge due to Phenotypic Variance J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1940 - 1945. [Abstract] [Full Text]

				A. Nikoshkov, S. Lajic, A. Vlamis-Gardikas, L. Tranebjarg, M. Holst, A. Wedell, and H. Luthman Naturally Occurring Mutants of Human Steroid 21-Hydroxylase (P450c21) Pinpoint Residues Important for Enzyme Activity and Stability J. Biol. Chem., March 13, 1998; 273(11): 6163 - 6165. [Abstract] [Full Text] [PDF]

				J. Jaaskelainen, A. Levo, R. Voutilainen, and J. Partanen Population-Wide Evaluation of Disease Manifestation in Relation to Molecular Genotype in Steroid 21-Hydroxylase (CYP21) Deficiency: Good Correlation in a Well Defined Population J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3293 - 3297. [Abstract] [Full Text] [PDF]

				T. Tajima, K. F. Jun Nakae, T. Toyoura, K. Shimozawa, S. Kusuda, K. Goji, T. Nagashima, and G. B. Cutler Jr. Molecular Basis of Nonclassical Steroid 21-Hydroxylase Deficiency Detected by Neonatal Mass Screening in Japan J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2350 - 2356. [Abstract] [Full Text] [PDF]

				R. Azziz and S. M. Slayden The 21-Hydroxylase-Deficient Adrenal Hyperplasias: More Than ACTH Oversecretion Reproductive Sciences, November 1, 1996; 3(6): 297 - 302. [Abstract] [PDF]